- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Latest News
Dragon nation allows patients to import drugs that are not registered with its regulator
New norms for drug...
Read More
New norms for drug...
Read More
All eyes on DCGI to see if it echoes the alert, since over 180 variants sell in India.
First, the alarm was...
Read More
First, the alarm was...
Read More
FRANKFURT: Merck KGaA's prospective lung cancer treatment tepotinib became the third drug against a rare and aggressive...
Read More
Read More
The U.S. Food and Drug Administration has approved Xeris Pharmaceuticals Inc's glucagon pen that aims to treat...
Read More
Read More
New Delhi: The Board of Directors of Sanofi India Limited (SIL) has approved a transaction for the slump sale and...
Read More
Read More
Sun Pharmaceutical Industries said its Netherlands-based arm has fully acquired PJSC Biosintez, Russia by purchasing...
Read More
Read More
Glenmark Pharmaceuticals, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration...
Read More
Read More
Canada's main pharmaceutical industry lobby group, along with 16 of its member companies, filed a lawsuit recently to...
Read More
Read More
Endo International plc ENDP announced that Novitium Pharma, LLC, a partner of its subsidiary Endo Ventures Limited,...
Read More
Read More
In Spain, at least 17 children developed a form of werewolf syndrome (a rare and curious condition that causes excessive...
Read More
Read More
Only two weeks back, Biocon’s insulin operations in Malaysia had won a certificate of good manufacturing practice from...
Read More
Read More
The drug industry in the US has been touching new lows. According to Gallup’s annual work and education survey,...
Read More
Read More